Boric Acid Exhibits Anticancer Properties in Human Endometrial Cancer Ishikawa Cells

被引:5
|
作者
Gundogdu, Ayse Cakor [1 ]
Ari, Neziha Senem [1 ]
Hobel, Asiye [1 ]
Eldiven, Omer [1 ]
Kar, Fatih [2 ]
机构
[1] Kutahya Hlth Sci Univ, Histol & Embryol, Kutahya, Turkiye
[2] Kutahya Univ Hlth Sci, Sch Med, Med Biochem, Kutahya, Turkiye
关键词
oxidative stress; inflammation; endometrial cancer; boric acid; apoptosis; OXIDATIVE STRESS; METASTASIS;
D O I
10.7759/cureus.44277
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective This study aims to explore the potential anti-cancer properties of boric acid (BA) in human endometrial cancer Ishikawa cells by assessing its influence on cell viability, apoptosis, oxidative stress, and inflammatory responses.Methods The impact of BA at concentrations ranging from 2.5 to 100 mM on cell viability was assessed in Ishikawa cells and normal fibroblast L929 cells (used as the control) through the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Spectrophotometric measurements were performed to determine the total oxidant status (TOS) and total antioxidant status (TAS) in BA-treated cells, and the oxidative stress index (OSI) was calculated. The enzyme-linked immunosorbent assay (ELISA) was used to measure the levels of cytochrome c and caspase 3, both of which are constituents of the extrinsic apoptotic pathway. Furthermore, changes in the concentrations of pro-inflammatory cytokines tumor necrosis factor-alpha (TNF-& alpha;) and interleukin-1beta (IL-113) in the cells were analyzed using ELISA and immunofluorescence staining. Results The exposure of Ishikawa cells to BA for 24 hours led to a dose-dependent decline in cell viability, with an IC50 value of 40 mM. BA dose-dependently increased cytochrome c and caspase 3 levels in cancer cells. In Ishikawa cells, BA treatment led to a significant elevation in OSI. Moreover, the concentrations of TNF-& alpha; and IL-113 exhibited a dose-dependent decrease in BA-treated cells. On the other hand, in L929 cells, BA decreased OSI in a dose-dependent manner but did not change TNF-& alpha; and IL-113 levels. Concentrations up to 80 mM had no effect on cell viability and apoptosis, but BA at 80 mM concentration decreased viability and increased cytochrome c and caspase 3 levels in L929 cells.Conclusion BA inhibited cell viability, triggered apoptosis, induced oxidative stress, and suppressed inflammatory responses in endometrial cancer cells. Notably, at its IC50 concentration, BA had no cytotoxic effect on normal fibroblasts. Given its favorable properties, BA may provide a valuable therapeutic option to impede the development and progression of endometrial cancer.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells
    Bhat, KPL
    Pezzuto, JM
    CANCER RESEARCH, 2001, 61 (16) : 6137 - 6144
  • [2] Acetaminophen exhibits weak antiestrogenic activity in human endometrial adenocarcinoma (Ishikawa) cells
    Dowdy, J
    Brower, S
    Miller, MR
    TOXICOLOGICAL SCIENCES, 2003, 72 (01) : 57 - 65
  • [3] Effects of curcuminoids on the cell cycle in human Ishikawa endometrial cancer cells
    Kratschmann, JS
    Pfeiffer, E
    Metzler, M
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 109 - 109
  • [4] Ramelteon Exhibits Anticancer Effects in Different Types of Human Cancer Cells
    Turkol, Senanur
    Keskin, Tuba
    Sekerci, Guldeniz
    Tekin, Cigdem
    Tekin, Suat
    ACTA PHYSIOLOGICA, 2025, 241 : 40 - 40
  • [5] ESTRADIOL METABOLISM IN ISHIKAWA ENDOMETRIAL CANCER-CELLS
    HATA, H
    HOLINKA, CF
    PAHUJA, SL
    HOCHBERG, RB
    KURAMOTO, H
    GURPIDE, E
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1987, 26 (06): : 699 - 704
  • [6] Gene regulation profiles by progesterone and dexamethasone in human endometrial cancer Ishikawa H cells
    Davies, S
    Dai, DH
    Pickett, G
    Leslie, KK
    GYNECOLOGIC ONCOLOGY, 2006, 101 (01) : 62 - 70
  • [7] Ascorbate exhibits anticancer effects in pre-clinical models of serous endometrial cancer cells
    Sinha, Nikita
    Shen, Xiaochang
    Deng, Boer
    Zhao, Ziyi
    Spasojevic, Ivan
    Secord, Angeles Alvarez
    Zhou, Chunxiao
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S210 - S211
  • [8] Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikawa endometrial cancer cells
    Wormke, M
    Castro-Rivera, E
    Chen, I
    Safe, S
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2000, 72 (05): : 197 - 207
  • [9] Growth-stimulatory and transcriptional activation properties of raloxifene in human endometrial Ishikawa cells
    Barsalou, A
    Dayan, G
    Anghel, SI
    Alaoui-Jamali, M
    Van de Velde, P
    Mader, S
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2002, 190 (1-2) : 65 - 73
  • [10] Multi-omics reveals the anticancer mechanism of asparagus saponin-asparanin A on endometrial cancer Ishikawa cells
    Zhang, Fan
    Zhang, Yuan-Yuan
    Ma, Run-Hui
    Thakur, Kiran
    Han, Jinzhi
    Hu, Fei
    Zhang, Jian-Guo
    Wei, Zhao-Jun
    FOOD & FUNCTION, 2021, 12 (02) : 614 - 632